BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26492786)

  • 1. [PREDICTORS OF FORMATION OF NEW FORMS--OF BRONCHOPULMONARY DYSPLASIA AT THE PRENATAL STAGE].
    Loginova OL; Senatorova GS
    Lik Sprava; 2014; (9-10):113-8. PubMed ID: 26492786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chorioamnionitis and bronchopulmonary dysplasia in evolution.
    Lands LC
    Paediatr Respir Rev; 2014 Mar; 15(1):47-8. PubMed ID: 24210583
    [No Abstract]   [Full Text] [Related]  

  • 3. Ureaplasma urealyticum: no independent role in the pathogenesis of bronchopulmonary dysplasia.
    Aaltonen R; Vahlberg T; Lehtonen L; Alanen A
    Acta Obstet Gynecol Scand; 2006; 85(11):1354-9. PubMed ID: 17091417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chorioamnionitis/funisitis and the development of bronchopulmonary dysplasia.
    Kent A; Dahlstrom JE
    J Paediatr Child Health; 2004 Jul; 40(7):356-9. PubMed ID: 15228562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antenatal factors and the development of bronchopulmonary dysplasia.
    Jobe AH
    Semin Neonatol; 2003 Feb; 8(1):9-17. PubMed ID: 12667826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal information of lungs and bronchopulmonary dysplasia.
    Grigg J
    Pediatrics; 1997 Jan; 99(1):144. PubMed ID: 8989357
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of chorioamnionitis and preeclampsia on neurodevelopmental outcome in preterm infants below 32 weeks gestational age.
    Schlapbach LJ; Ersch J; Adams M; Bernet V; Bucher HU; Latal B
    Acta Paediatr; 2010 Oct; 99(10):1504-9. PubMed ID: 20456275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chorioamnionitis, lung function and bronchopulmonary dysplasia in prematurely born infants.
    Prendergast M; May C; Broughton S; Pollina E; Milner AD; Rafferty GF; Greenough A
    Arch Dis Child Fetal Neonatal Ed; 2011 Jul; 96(4):F270-4. PubMed ID: 21097839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ureaplasma-associated prenatal, perinatal, and neonatal morbidities.
    Silwedel C; Speer CP; Glaser K
    Expert Rev Clin Immunol; 2017 Nov; 13(11):1073-1087. PubMed ID: 28918659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of gastric fluid microbes at birth with severe bronchopulmonary dysplasia.
    Oue S; Hiroi M; Ogawa S; Hira S; Hasegawa M; Yamaoka S; Yasui M; Tamai H; Ogihara T
    Arch Dis Child Fetal Neonatal Ed; 2009 Jan; 94(1):F17-22. PubMed ID: 18676413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inflammation and bronchopulmonary dysplasia].
    Lopez E; Jarreau PH
    Med Sci (Paris); 2013 Oct; 29(10):823-5. PubMed ID: 24148114
    [No Abstract]   [Full Text] [Related]  

  • 12. The association of histological chorioamnionitis and antenatal steroids on neonatal outcome in preterm infants born at less than thirty-four weeks' gestation.
    Ahn HM; Park EA; Cho SJ; Kim YJ; Park HS
    Neonatology; 2012; 102(4):259-64. PubMed ID: 22907714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ureaplasma and bronchopulmonary dysplasia.
    Gancia P; Delogu A; Pomero G
    Early Hum Dev; 2014 Mar; 90 Suppl 1():S39-41. PubMed ID: 24709455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of Ureaplasma urealyticum in bronchopulmonary dysplasia of prematurity].
    Bao Y; Zhao ZY; Shi LP; Ma XL; Chen Z; Luo F
    Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):767-70. PubMed ID: 23302568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchopulmonary dysplasia: prenatal and postnatal influences.
    Hislop AA
    Pediatr Pulmonol; 2001; Suppl 23():107-9. PubMed ID: 11886106
    [No Abstract]   [Full Text] [Related]  

  • 16. Prenatal inflammatory risk factors for development of bronchopulmonary dysplasia.
    Eriksson L; Haglund B; Odlind V; Altman M; Kieler H
    Pediatr Pulmonol; 2014 Jul; 49(7):665-72. PubMed ID: 24039136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The levels of the neutrophil elastase in the amniotic fluid of pregnant women whose infants develop bronchopulmonary dysplasia.
    Ikeda S; Kihira K; Yokoi A; Tamakoshi K; Miyazaki K; Furuhashi M
    J Matern Fetal Neonatal Med; 2015 Mar; 28(4):479-83. PubMed ID: 24803125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic fetal inflammation and reduced concentrations of macrophage migration inhibitory factor in tracheobronchial aspirate fluid of extremely premature infants.
    Thomas W; Seidenspinner S; KawczyƄska-Leda N; Kramer BW; Chmielnicka-Kopaczyk M; Marx A; Szymankiewicz M; Speer CP
    Am J Obstet Gynecol; 2008 Jan; 198(1):64.e1-6. PubMed ID: 18166309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The airway microbiome of intubated premature infants: characteristics and changes that predict the development of bronchopulmonary dysplasia.
    Lohmann P; Luna RA; Hollister EB; Devaraj S; Mistretta TA; Welty SE; Versalovic J
    Pediatr Res; 2014 Sep; 76(3):294-301. PubMed ID: 24941215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops.
    Watterberg KL; Demers LM; Scott SM; Murphy S
    Pediatrics; 1996 Feb; 97(2):210-5. PubMed ID: 8584379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.